Broad Coverage: Utilizes more than 200 antibodies to develop 3-D conformational fingerprint
Intelligent Database: Data analysis is supported by extensive databank containing 150+ innovator and biosimilar fingerprints
Artificial Intelligence Driven Data Analysis
Glycan Profiling
Predictive of Functional Activities:
Target binding
ADCC and CDC activity
Fc Receptor binding
Intelli.b – Biosimilar Fingerprinting Technology
Somru BioScience has developed Intelli.b™ – a platform for the comparability testing of biosimilars at a molecular level that meets the intent of the FDA guidance for fingerprint-like analysis. The Intelli.b™ platform is an integrated, multi-parameter approach that is extremely sensitive in identifying analytical differences (i.e. fingerprint-like analysis).